One possible cause of the stock price struggle is that there has...

One possible cause of the stock price struggle is that there has been some serious turnover in Health Roundtable client support roles - with the departure of two key people recently (one in WA and one in NSW) - as shown on their profiles in Linkedin.

The Health Roundtable is apparently moving away from "roundtable discussions" to focus on delivery of online benchmarking analytics.

This is a big shift in strategy IMHO that was announced to the staff, but not significant enough to inform the market formally. The Roundtable still represents almost half of all revenue.

A big question is who actually owns the Intellectual Property underlying the Health Roundtable analytics. Originally, the non-profit Health Roundtable owned all the IP and simply licensed it to the for-profit service provider. It is not clear whether the $1 million investments by the Roundtable and Beamtree in the new IT system will result in co-ownership or not.

Looking forward to seeing the Health Roundtable annual report for the 2023 calendar year, which should be released on the ACNC government website by the end of June...